Heyedrate Clinical by EyePromise was discussed in Review of Optometry, a leading publication for eye care professionals, as part of a clinical conversation about modern dry eye treatment.
In that discussion, the product was referenced as a hyaluronic acid-based artificial tear and noted for its ultra-high molecular weight hyaluronic acid formulation—an important distinction in how artificial tears support eye hydration and ocular surface comfort.
The article explored the evolving role of artificial tears within dry eye management and positioned Heyedrate Clinical within a broader conversation about ingredient quality, formulation differences, and practical symptom support.
For patients and shoppers researching dry eye relief, this mention provides meaningful third-party context when comparing eye drops and understanding how formulations may differ.
Key Takeaways
• Heyedrate Clinical was discussed in Optometric Physician / Review of Optometry in the context of artificial tears and dry eye management.
• The article identified Heyedrate Clinical as a hyaluronic acid-based artificial tear from EyePromise.
• The publication noted Heyedrate Clinical as the first and currently only ultra-high molecular weight hyaluronic acid drop available in the U.S. within that discussion and how molecular weight may influence how artificial tears perform on the ocular surface.
• For shoppers, the mention provides third-party context from an optometry publication while they compare dry eye relief options.
• For eye care professionals and clinically minded users, the article reinforces the relevance of molecular weight, formulation quality, and ocular surface hydration in artificial tear selection.
Why This Feature Matters
Being discussed in a respected optometry publication is meaningful because eye care professionals, industry leaders, and clinically minded patients look to sources like Review of Optometry and Optometric Physician for informed perspectives on emerging products, ingredients, and care approaches.
While not an endorsement, inclusion in a professional optometry publication places Heyedrate Clinical within a credible, clinician-led discussion about effective dry eye support solutions. This context is valuable because the article did not position Heyedrate Clinical in isolation—it included the product within a broader conversation about artificial tears, hyaluronic acid, dry eye symptoms, and how formulation differences may contribute to ocular surface hydration.
For EyePromise, this type of mention reinforces broader brand authority. It connects Heyedrate Clinical to the same science-aware, doctor-trusted positioning that underpins the EyePromise approach to eye health and daily ocular wellness.
For shoppers, it provides a meaningful trust signal during the decision-making process. When evaluating eye drops for dry eye relief, consumers often look beyond packaging claims—they want to understand whether a product is part of a clinically relevant, professional conversation. Inclusion in that type of discussion helps add useful context as they compare options and make more informed choices.
About the Article
The April 6, 2026 issue of Optometric Physician included an article titled “Off the Cuff: Going Ultra: An Intriguing New Artificial Tear.” The piece discussed the role artificial tears can play in dry eye management, particularly for lubrication, symptom support, and use alongside broader dry eye care approaches.
Within that discussion, Heyedrate Clinical by EyePromise was referenced as a newer hyaluronic acid-based artificial tear. The article highlighted the distinction between different molecular weights of hyaluronic acid and identified Heyedrate Clinical as an ultra-high molecular weight hyaluronic acid drop available in the U.S.
The article’s focus was not a general product announcement. It placed Heyedrate Clinical within a practical clinical conversation about artificial tears, dry eye care, and how formulation differences may matter when supporting the ocular surface.
To read the original article, visit the full publication on Review of Optometry.
What this means for patients & shoppers
For patients researching dry eye relief, the publication mention helps answer a simple question: why pay attention to this eye drop?
Heyedrate Clinical is relevant because it uses hyaluronic acid, an ingredient commonly used in artificial tears for lubrication and eye hydration support. The article’s discussion of ultra-high molecular weight hyaluronic acid provides helpful context for shoppers who want to understand how one artificial tear may differ from another.
This does not mean every person with dry eye needs the same product or that an artificial tear replaces professional care. Dry eye can have many causes, and persistent symptoms should be discussed with an eye care professional.
For daily shoppers, the takeaway is more practical: Heyedrate Clinical is an EyePromise artificial tear designed for people looking for a doctor-trusted, hydration-focused dry eye drop from a brand rooted in clinically backed eye care.
